Stock Analysis on Net
Stock Analysis on Net

Abiomed Inc. (NASDAQ:ABMD)

This company has been moved to the archive! The financial data has not been updated since November 3, 2022.

Adjusted Financial Ratios

Microsoft Excel

Adjusted Financial Ratios (Summary)

Abiomed Inc., adjusted financial ratios

Microsoft Excel
Mar 31, 2022 Mar 31, 2021 Mar 31, 2020 Mar 31, 2019 Mar 31, 2018 Mar 31, 2017
Activity Ratio
Total Asset Turnover
Reported 0.62 0.57 0.69 0.73 0.76 0.81
Adjusted 0.62 0.57 0.72 0.78 0.82 0.85
Liquidity Ratio
Current Ratio
Reported 7.05 6.11 4.82 6.39 5.84 4.70
Adjusted 8.87 7.69 5.74 7.68 7.21 5.60
Solvency Ratios
Debt to Equity
Reported 0.00 0.00 0.00 0.00 0.00 0.04
Adjusted 0.01 0.00 0.01 0.02 0.02 0.06
Debt to Capital
Reported 0.00 0.00 0.00 0.00 0.00 0.03
Adjusted 0.01 0.00 0.01 0.02 0.02 0.05
Financial Leverage
Reported 1.11 1.12 1.14 1.13 1.14 1.22
Adjusted 1.09 1.10 1.12 1.13 1.14 1.22
Profitability Ratios
Net Profit Margin
Reported 13.23% 26.61% 24.14% 33.66% 18.89% 11.70%
Adjusted 12.09% 30.45% 28.79% 31.54% 29.43% 16.43%
Return on Equity (ROE)
Reported 9.08% 16.96% 19.05% 27.65% 16.27% 11.53%
Adjusted 8.21% 19.28% 23.24% 27.66% 27.68% 17.10%
Return on Assets (ROA)
Reported 8.16% 15.09% 16.69% 24.57% 14.26% 9.47%
Adjusted 7.51% 17.50% 20.69% 24.50% 24.25% 14.03%

Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31).

Financial ratio Description The company
Adjusted total asset turnover An activity ratio calculated as total revenue divided by adjusted total assets. Abiomed Inc. adjusted total asset turnover ratio deteriorated from 2020 to 2021 but then slightly improved from 2021 to 2022.
Adjusted current ratio A liquidity ratio calculated as adjusted current assets divided by adjusted current liabilities. Abiomed Inc. adjusted current ratio improved from 2020 to 2021 and from 2021 to 2022.
Adjusted debt-to-equity ratio A solvency ratio calculated as adjusted total debt divided by adjusted total equity. Abiomed Inc. adjusted debt-to-equity ratio improved from 2020 to 2021 but then slightly deteriorated from 2021 to 2022.
Adjusted debt-to-capital ratio A solvency ratio calculated as adjusted total debt divided by adjusted total debt plus adjusted total equity. Abiomed Inc. adjusted debt-to-capital ratio improved from 2020 to 2021 but then slightly deteriorated from 2021 to 2022.
Adjusted financial leverage A measure of financial leverage calculated as adjusted total assets divided by adjusted total equity.
Financial leverage is the extent to which a company can effect, through the use of debt, a proportional change in the return on common equity that is greater than a given proportional change in operating income.		 Abiomed Inc. adjusted financial leverage ratio decreased from 2020 to 2021 and from 2021 to 2022.
Adjusted net profit margin An indicator of profitability, calculated as adjusted net income divided by total revenue. Abiomed Inc. adjusted net profit margin ratio improved from 2020 to 2021 but then deteriorated significantly from 2021 to 2022.
Adjusted ROE A profitability ratio calculated as adjusted net income divided by adjusted total equity. Abiomed Inc. adjusted ROE deteriorated from 2020 to 2021 and from 2021 to 2022.
Adjusted ROA A profitability ratio calculated as adjusted net income divided by adjusted total assets. Abiomed Inc. adjusted ROA deteriorated from 2020 to 2021 and from 2021 to 2022.

Abiomed Inc., Financial Ratios: Reported vs. Adjusted

Adjusted Total Asset Turnover

Microsoft Excel
Mar 31, 2022 Mar 31, 2021 Mar 31, 2020 Mar 31, 2019 Mar 31, 2018 Mar 31, 2017
Reported
Selected Financial Data (US$ in thousands)
Revenue 1,031,753 847,522 840,883 769,432 593,749 445,304
Total assets 1,673,393 1,494,359 1,216,462 1,054,346 786,375 550,414
Activity Ratio
Total asset turnover1 0.62 0.57 0.69 0.73 0.76 0.81
Adjusted
Selected Financial Data (US$ in thousands)
Adjusted revenue2 1,033,793 852,697 843,637 770,855 598,224 447,021
Adjusted total assets3 1,663,465 1,483,753 1,174,328 992,158 726,038 523,435
Activity Ratio
Adjusted total asset turnover4 0.62 0.57 0.72 0.78 0.82 0.85

Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31).

1 2022 Calculation
Total asset turnover = Revenue ÷ Total assets
= 1,031,753 ÷ 1,673,393 = 0.62

2 Adjusted revenue. See details »

3 Adjusted total assets. See details »

4 2022 Calculation
Adjusted total asset turnover = Adjusted revenue ÷ Adjusted total assets
= 1,033,793 ÷ 1,663,465 = 0.62

Activity ratio Description The company
Adjusted total asset turnover An activity ratio calculated as total revenue divided by adjusted total assets. Abiomed Inc. adjusted total asset turnover ratio deteriorated from 2020 to 2021 but then slightly improved from 2021 to 2022.

Adjusted Current Ratio

Microsoft Excel
Mar 31, 2022 Mar 31, 2021 Mar 31, 2020 Mar 31, 2019 Mar 31, 2018 Mar 31, 2017
Reported
Selected Financial Data (US$ in thousands)
Current assets 976,473 787,965 635,863 677,197 494,271 326,958
Current liabilities 138,457 128,969 131,885 105,998 84,682 69,617
Liquidity Ratio
Current ratio1 7.05 6.11 4.82 6.39 5.84 4.70
Adjusted
Selected Financial Data (US$ in thousands)
Adjusted current assets2 977,097 788,739 637,065 678,237 494,591 327,240
Adjusted current liabilities3 110,160 102,594 110,920 88,333 68,631 58,405
Liquidity Ratio
Adjusted current ratio4 8.87 7.69 5.74 7.68 7.21 5.60

Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31).

1 2022 Calculation
Current ratio = Current assets ÷ Current liabilities
= 976,473 ÷ 138,457 = 7.05

2 Adjusted current assets. See details »

3 Adjusted current liabilities. See details »

4 2022 Calculation
Adjusted current ratio = Adjusted current assets ÷ Adjusted current liabilities
= 977,097 ÷ 110,160 = 8.87

Liquidity ratio Description The company
Adjusted current ratio A liquidity ratio calculated as adjusted current assets divided by adjusted current liabilities. Abiomed Inc. adjusted current ratio improved from 2020 to 2021 and from 2021 to 2022.

Adjusted Debt to Equity

Microsoft Excel
Mar 31, 2022 Mar 31, 2021 Mar 31, 2020 Mar 31, 2019 Mar 31, 2018 Mar 31, 2017
Reported
Selected Financial Data (US$ in thousands)
Total debt — — — — — 16,338
Stockholders’ equity 1,503,326 1,329,675 1,065,466 936,890 689,524 452,071
Solvency Ratio
Debt to equity1 0.00 0.00 0.00 0.00 0.00 0.04
Adjusted
Selected Financial Data (US$ in thousands)
Adjusted total debt2 9,507 6,116 12,220 14,274 10,089 23,800
Adjusted stockholders’ equity3 1,522,476 1,346,291 1,045,103 878,915 636,052 429,625
Solvency Ratio
Adjusted debt to equity4 0.01 0.00 0.01 0.02 0.02 0.06

Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31).

1 2022 Calculation
Debt to equity = Total debt ÷ Stockholders’ equity
= 0 ÷ 1,503,326 = 0.00

2 Adjusted total debt. See details »

3 Adjusted stockholders’ equity. See details »

4 2022 Calculation
Adjusted debt to equity = Adjusted total debt ÷ Adjusted stockholders’ equity
= 9,507 ÷ 1,522,476 = 0.01

Solvency ratio Description The company
Adjusted debt-to-equity ratio A solvency ratio calculated as adjusted total debt divided by adjusted total equity. Abiomed Inc. adjusted debt-to-equity ratio improved from 2020 to 2021 but then slightly deteriorated from 2021 to 2022.

Adjusted Debt to Capital

Microsoft Excel
Mar 31, 2022 Mar 31, 2021 Mar 31, 2020 Mar 31, 2019 Mar 31, 2018 Mar 31, 2017
Reported
Selected Financial Data (US$ in thousands)
Total debt — — — — — 16,338
Total capital 1,503,326 1,329,675 1,065,466 936,890 689,524 468,409
Solvency Ratio
Debt to capital1 0.00 0.00 0.00 0.00 0.00 0.03
Adjusted
Selected Financial Data (US$ in thousands)
Adjusted total debt2 9,507 6,116 12,220 14,274 10,089 23,800
Adjusted total capital3 1,531,983 1,352,407 1,057,323 893,189 646,141 453,425
Solvency Ratio
Adjusted debt to capital4 0.01 0.00 0.01 0.02 0.02 0.05

Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31).

1 2022 Calculation
Debt to capital = Total debt ÷ Total capital
= 0 ÷ 1,503,326 = 0.00

2 Adjusted total debt. See details »

3 Adjusted total capital. See details »

4 2022 Calculation
Adjusted debt to capital = Adjusted total debt ÷ Adjusted total capital
= 9,507 ÷ 1,531,983 = 0.01

Solvency ratio Description The company
Adjusted debt-to-capital ratio A solvency ratio calculated as adjusted total debt divided by adjusted total debt plus adjusted total equity. Abiomed Inc. adjusted debt-to-capital ratio improved from 2020 to 2021 but then slightly deteriorated from 2021 to 2022.

Adjusted Financial Leverage

Microsoft Excel
Mar 31, 2022 Mar 31, 2021 Mar 31, 2020 Mar 31, 2019 Mar 31, 2018 Mar 31, 2017
Reported
Selected Financial Data (US$ in thousands)
Total assets 1,673,393 1,494,359 1,216,462 1,054,346 786,375 550,414
Stockholders’ equity 1,503,326 1,329,675 1,065,466 936,890 689,524 452,071
Solvency Ratio
Financial leverage1 1.11 1.12 1.14 1.13 1.14 1.22
Adjusted
Selected Financial Data (US$ in thousands)
Adjusted total assets2 1,663,465 1,483,753 1,174,328 992,158 726,038 523,435
Adjusted stockholders’ equity3 1,522,476 1,346,291 1,045,103 878,915 636,052 429,625
Solvency Ratio
Adjusted financial leverage4 1.09 1.10 1.12 1.13 1.14 1.22

Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31).

1 2022 Calculation
Financial leverage = Total assets ÷ Stockholders’ equity
= 1,673,393 ÷ 1,503,326 = 1.11

2 Adjusted total assets. See details »

3 Adjusted stockholders’ equity. See details »

4 2022 Calculation
Adjusted financial leverage = Adjusted total assets ÷ Adjusted stockholders’ equity
= 1,663,465 ÷ 1,522,476 = 1.09

Solvency ratio Description The company
Adjusted financial leverage A measure of financial leverage calculated as adjusted total assets divided by adjusted total equity.
Financial leverage is the extent to which a company can effect, through the use of debt, a proportional change in the return on common equity that is greater than a given proportional change in operating income.		 Abiomed Inc. adjusted financial leverage ratio decreased from 2020 to 2021 and from 2021 to 2022.

Adjusted Net Profit Margin

Microsoft Excel
Mar 31, 2022 Mar 31, 2021 Mar 31, 2020 Mar 31, 2019 Mar 31, 2018 Mar 31, 2017
Reported
Selected Financial Data (US$ in thousands)
Net income 136,505 225,525 203,009 259,016 112,170 52,116
Revenue 1,031,753 847,522 840,883 769,432 593,749 445,304
Profitability Ratio
Net profit margin1 13.23% 26.61% 24.14% 33.66% 18.89% 11.70%
Adjusted
Selected Financial Data (US$ in thousands)
Adjusted net income2 124,975 259,631 242,924 243,120 176,073 73,447
Adjusted revenue3 1,033,793 852,697 843,637 770,855 598,224 447,021
Profitability Ratio
Adjusted net profit margin4 12.09% 30.45% 28.79% 31.54% 29.43% 16.43%

Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31).

1 2022 Calculation
Net profit margin = 100 × Net income ÷ Revenue
= 100 × 136,505 ÷ 1,031,753 = 13.23%

2 Adjusted net income. See details »

3 Adjusted revenue. See details »

4 2022 Calculation
Adjusted net profit margin = 100 × Adjusted net income ÷ Adjusted revenue
= 100 × 124,975 ÷ 1,033,793 = 12.09%

Profitability ratio Description The company
Adjusted net profit margin An indicator of profitability, calculated as adjusted net income divided by total revenue. Abiomed Inc. adjusted net profit margin ratio improved from 2020 to 2021 but then deteriorated significantly from 2021 to 2022.

Adjusted Return on Equity (ROE)

Microsoft Excel
Mar 31, 2022 Mar 31, 2021 Mar 31, 2020 Mar 31, 2019 Mar 31, 2018 Mar 31, 2017
Reported
Selected Financial Data (US$ in thousands)
Net income 136,505 225,525 203,009 259,016 112,170 52,116
Stockholders’ equity 1,503,326 1,329,675 1,065,466 936,890 689,524 452,071
Profitability Ratio
ROE1 9.08% 16.96% 19.05% 27.65% 16.27% 11.53%
Adjusted
Selected Financial Data (US$ in thousands)
Adjusted net income2 124,975 259,631 242,924 243,120 176,073 73,447
Adjusted stockholders’ equity3 1,522,476 1,346,291 1,045,103 878,915 636,052 429,625
Profitability Ratio
Adjusted ROE4 8.21% 19.28% 23.24% 27.66% 27.68% 17.10%

Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31).

1 2022 Calculation
ROE = 100 × Net income ÷ Stockholders’ equity
= 100 × 136,505 ÷ 1,503,326 = 9.08%

2 Adjusted net income. See details »

3 Adjusted stockholders’ equity. See details »

4 2022 Calculation
Adjusted ROE = 100 × Adjusted net income ÷ Adjusted stockholders’ equity
= 100 × 124,975 ÷ 1,522,476 = 8.21%

Profitability ratio Description The company
Adjusted ROE A profitability ratio calculated as adjusted net income divided by adjusted total equity. Abiomed Inc. adjusted ROE deteriorated from 2020 to 2021 and from 2021 to 2022.

Adjusted Return on Assets (ROA)

Microsoft Excel
Mar 31, 2022 Mar 31, 2021 Mar 31, 2020 Mar 31, 2019 Mar 31, 2018 Mar 31, 2017
Reported
Selected Financial Data (US$ in thousands)
Net income 136,505 225,525 203,009 259,016 112,170 52,116
Total assets 1,673,393 1,494,359 1,216,462 1,054,346 786,375 550,414
Profitability Ratio
ROA1 8.16% 15.09% 16.69% 24.57% 14.26% 9.47%
Adjusted
Selected Financial Data (US$ in thousands)
Adjusted net income2 124,975 259,631 242,924 243,120 176,073 73,447
Adjusted total assets3 1,663,465 1,483,753 1,174,328 992,158 726,038 523,435
Profitability Ratio
Adjusted ROA4 7.51% 17.50% 20.69% 24.50% 24.25% 14.03%

Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31).

1 2022 Calculation
ROA = 100 × Net income ÷ Total assets
= 100 × 136,505 ÷ 1,673,393 = 8.16%

2 Adjusted net income. See details »

3 Adjusted total assets. See details »

4 2022 Calculation
Adjusted ROA = 100 × Adjusted net income ÷ Adjusted total assets
= 100 × 124,975 ÷ 1,663,465 = 7.51%

Profitability ratio Description The company
Adjusted ROA A profitability ratio calculated as adjusted net income divided by adjusted total assets. Abiomed Inc. adjusted ROA deteriorated from 2020 to 2021 and from 2021 to 2022.